Xie Lan 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Aug 16, 2017
Insider Transaction Report
Form 4
Xie Lan
VP Finance China, CFO
Transactions
- Exercise/Conversion
Common Stock
2017-08-15+10,000→ 10,000 total - Sale
Common Stock
2017-08-16$11.00/sh−10,000$110,000→ 0 total - Exercise/Conversion
Restricted Stock Unit
2017-08-15−10,000→ 8,000 total→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F3]Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.